溶酶体储存障碍 (LSD) 的自然历史映射:高希氏病作为精密护理模型
Noor Ul Ain1, Maya Vaishnaw2, Pramod K Mistry3
1Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Journal of inherited metabolic disease
|January 13, 2026
概括
通过深度表型和先进分析增强的自然历史数据,对于开发罕见疾病治疗非常重要. 氏病为将注册表转化为精准医学预测工具提供了一个模型.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 生物标志物和诊断方法
- 药物开发和监管科学 药物开发和监管科学
背景情况:
- 自然史数据集对于罕见疾病药物开发和临床指南至关重要.
- 溶酶体储存障碍 (LSD) 需要改进表型和分析方法.
- 氏病 (GD) 作为整合数据和推进LSD研究的模型.
研究的目的:
- 开发一个实际的框架来捕获和解释罕见疾病的自然历史数据.
- 将基因组,细胞,治疗和监管方面的进展整合到这个框架中.
- 利用高氏病作为这种整合的范例.
主要方法:
- 审查了300多篇同行评审的文章 (2005-2025年),FDA指导和现实世界的注册数据.
- 专注于长期阅读的GBA测序,lyso-Gb1生物标志物,新生儿查和多状态疾病建模.
- 分析了基因型-表型相关性和注册表轨迹.
主要成果:
- 全基因测序确定了70多个GBA等位基因,影响了小组测试.
- 多州模型显示了跟踪治疗修改的疾病过程和无声终点的潜力.
- 莱索-Gb1是一种优越的生物标志物和二级新生儿查标志物.
- 自然历史数据支持监管部门对几种LSD的批准,使得登记册可以作为外部控制.
结论:
- 深度表型,基因型意识分析和生物标志物捕获可以将注册表转化为预测引擎.
- 氏病提供了一个模板,可以在LSD中加速精密护理和下一代治疗方法.
- 这种综合方法可以增强药物开发和治疗罕见遗传疾病的患者护理.
相关概念视频
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K


